The market of biologics is growing at a nearly twice the rate of pharma as a whole. Biobetters are the next big opportunity for biopharma to benefit from this growth. This podcast will explore the regulatory and scientific considerations for the development of biobetters.
Thought Leader: Hazel Gorham, Ph.D., Director, Biosimilars Development, PRA
Play podcast
Showing posts with label Hazel Gorham. Show all posts
Showing posts with label Hazel Gorham. Show all posts
Monday, December 30, 2013
Subscribe to:
Posts (Atom)